Portfolio
Coming soon in 2024
Our team’s prior investment highlights
Laronde is an endless RNA platform with novel circular RNA drugs.
IPO
4DMT is a gene therapy company with a novel AAV discovery platform.
Valo Health is an end-to-end AI drug discovery and development platform.
Insilico Medicine is an AI drug discovery platform for longevity and biotech.
Freenome is a multi-analyte AI and genomics-based liquid biopsy platform.
Life Biosciences is a longevity biotech holding developing therapies for age-related diseases.
EXO Imaging is an AI-enabled handheld ultrasound device for high quality imaging.